Literature DB >> 6811336

Effect of body weight reduction on plasma androgens in obese, infertile women.

G W Bates, N S Whitworth.   

Abstract

Although a variety of disorders are associated with polycystic ovarian disease (PCOD), obesity, hirsutism, and menstrual dysfunction are the most frequent manifestations. We investigated the possibility that obesity per se may give rise to androgen excess through alterations in estrogen metabolism and, consequently, through alterations in gonadotropin secretion. Eighteen obese, infertile women with PCOD were compared with 20 control women. Plasma androstenedione (A) was 252 +/- 18 ng/dl (mean +/- standard error of the mean [SEM]) in the obese women compared with 173 +/- 9 ng/dl in the controls (P less than 0.001); plasma testosterone (T) was 66 +/- 5.7 ng/dl, compared with 41 +/- 3 ng/dl (P less than 0.001). Thirteen of the obese women lost greater than 15% of their body weight by dietary restriction; ten of these women (77%) conceived spontaneously. In seven of the ten women who conceived, we remeasured plasma androgens following weight reduction but prior to conception. A decreased from 295 +/- 19 ng/dl to 179 +/- 5 ng/dl; T decreased from 75 +/- 8 ng/dl to 39 +/- 5 ng/dl (P less than 0.001). We conclude that obesity may play a role in the genesis of PCOD.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811336

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

Review 1.  How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome?

Authors:  C Cortet-Rudelli; D Dewailly
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 2.  Insulin resistance, polycystic ovary syndrome and metformin.

Authors:  M Pugeat; P H Ducluzeau
Journal:  Drugs       Date:  1999       Impact factor: 9.546

3.  Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model.

Authors:  Ilana B Ressler; Bernadette E Grayson; Yvonne M Ulrich-Lai; Randy J Seeley
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-14       Impact factor: 4.310

Review 4.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

5.  Moderate energy restriction with high protein diet results in healthier outcome in women.

Authors:  Antti A Mero; Heikki Huovinen; Olle Matintupa; Juha J Hulmi; Risto Puurtinen; Hannele Hohtari; Tuomo Am Karila
Journal:  J Int Soc Sports Nutr       Date:  2010-01-25       Impact factor: 5.150

6.  Growth hormone administration normalizes the ovarian responsiveness to follicle-stimulating-hormone in the early stages of the follicular maturation in women with Down syndrome.

Authors:  R M Cento; L Ragusa; C Proto; A Alberti; G Fiore; L Soranna; F Colabucci; A Lanzone
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

7.  Feasibility of a brief, intensive weight loss intervention to improve reproductive outcomes in obese, subfertile women: a pilot study.

Authors:  Amy Rothberg; Michael Lanham; John Randolph; Christine Fowler; Nicole Miller; Yolanda Smith
Journal:  Fertil Steril       Date:  2016-06-20       Impact factor: 7.329

8.  Myo-Inositol in the Treatment of Teenagers Affected by PCOS.

Authors:  Lali Pkhaladze; Ludmila Barbakadze; Nana Kvashilava
Journal:  Int J Endocrinol       Date:  2016-08-18       Impact factor: 3.257

9.  Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS).

Authors:  Pascal Froment; Philippe Touraine
Journal:  PPAR Res       Date:  2006       Impact factor: 4.964

10.  The effects of thylakoid-rich spinach extract and aqueous extract of caraway (Carum carvi L.) in letrozole-induced polycystic ovarian syndrome rats.

Authors:  Saeed Sherafatmanesh; Maryam Ekramzadeh; Nader Tanideh; Mohammad-Taghi Golmakani; Farhad Koohpeyma
Journal:  BMC Complement Med Ther       Date:  2020-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.